Impulse control disorders and dopamine dysregulation in Parkinson's disease: A broader conceptual framework

European Journal of Neurology

Volumn 18, Issue 12, 2011, Pages 1379-1383

  Okai, D ^a   Samuel, M ^b   Askey Jones, S ^a   David, A S ^a   Brown, R G ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c East Kent Hospitals University Foundation Trust   (United Kingdom)

Author keywords

Addiction; Diagnosis; Disinhibition; Dysphoria; Gambling; Hypersexuality; Severity

Indexed keywords

DOPAMINE;

ANXIETY; CONCEPTUAL FRAMEWORK; CYCLOTHYMIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISTRESS SYNDROME; DOPAMINE DYSREGULATION SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG OVERDOSE; DRUG SEEKING BEHAVIOR; DYSPHORIA; EUPHORIA; FINANCIAL MANAGEMENT; HARM REDUCTION; HUMAN; HYPERSEXUALITY; HYPOMANIA; IMPULSE CONTROL DISORDER; IRRITABILITY; JOB PERFORMANCE; LEGAL ASPECT; MANIA; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PHOBIA; PRIORITY JOURNAL; REVIEW; SHOPPING; SOCIAL ASPECT; SOCIOPATHY; TASK PERFORMANCE;

ANTIPARKINSON AGENTS; DOPAMINE; DOPAMINE AGONISTS; FRONTAL LOBE; HUMANS; IMPULSE CONTROL DISORDERS; INHIBITION (PSYCHOLOGY); MODELS, PSYCHOLOGICAL; MOOD DISORDERS; MOTIVATION; NUCLEUS ACCUMBENS; OVERDOSE; PARKINSON DISEASE; REINFORCEMENT (PSYCHOLOGY); REWARD; SELF MEDICATION;

EID: 81855194016     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03432.x     Document Type: Review

References (32)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Version IV (DSM-IV-RT). Washington DC: American Psychiatric Association, 1994.
2. Hollander E, Allen A. Is compulsive buying a real disorder, and is it really compulsive? Am J Psychiaty 2006; 163: 1670-1672.
3. Marks I. Behavioural (non-chemical) addictions. Br J Addict 1990; 85: 1389-1394.
4. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001; 292: 2499-2501.
5. Volkow ND, Wang GJ, Ma Y, et al. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 2005; 25: 3932-3939.
6. Molina JA, Sainz-Artiga MJ, Fraile A, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 2000; 15: 869-872.
7. Potenza MN, Kosten TR, Rounsaville BJ. Pathological gambling. JAMA 2001; 286: 141-144.
8. Rao H, Mamikonyan E, Detre JA, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord 2010; 25: 1660-1669.
9. Gorenstein EE, Newman JP. Disinhibitory psychopathology: a new perspective and a model for research. Psychol Rev 1980; 87: 301-315.
10. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001; 39: 376-389.
11. Clark L, Robbins TW. Decision-making deficits in drug addiction. Trends Cogn Sci 2002; 6: 361-363.
12. Helzer J, Kraemer HC, Krueger RF, Wittchen HU, Sirovatka PS, Regier DA. Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-V. Arlington, Virginia: American Psychiatric Publishing, Inc., 2008.
13. Volberg RA, Abbott MW. Lifetime prevalence estimates of pathological gambling in New Zealand. Int J Epidemiol 1994; 23: 976-983.
14. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Publ Health 1999; 89: 1369-1376.
15. Cooke MA, Peters ER, Greenwood KE, Fisher PL, Kumari V, Kuipers E. Insight in psychosis: influence of cognitive ability and self-esteem. Br J Psychiatry 2007; 191: 234-237.
16. Todes CJ, Lees AJ. The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985; 48: 97-100.
17. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol, 2007; 64: 1089-1096.
18. Bechara A, Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002; 40: 1675-1689.
19. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397-405.
20. O'Sullivan SS, Djamshidian A, Evans AH, Loane CM, Lees AJ, Lawrence AD. Excessive hoarding in Parkinson's disease. Mov Disord 2010; 25: 1026-1033.
21. Mataix-Cols D, do Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228-238.
22. Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002; 71: 255-262.
23. Mataix-Cols D, Frost RO, Pertusa A, et al. Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety 2010; 27: 556-572.
24. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423-428.
25. Steeves TDL, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132: 1376-1385.
26. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008; 65: 1604-1611.
27. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852-858.
28. Berridge KC, Robinson TE. The mind of an addicted brain: neural sensitization of wanting versus liking. Curr Dir Psychol Sci 1995; 4: 71-76.
29. Bearn J, Evans A, Kelleher M, Turner K, Lees A. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study. Drug Alcohol Depend 2004; 76: 305-310.
30. Maricle RA, Nutt JG, Carter JH. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Mov Disord 1995; 10: 329-332.
31. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010; 67: 58-63.
32. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: 410-416.